English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/8239
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer

AuthorsIsidoro, Antonio; Martínez-Díez, Marta; Fernández, Pedro L.; Ortega, Álvaro D.; Santamaría, Gema; Chamorro, Margarita ; Reed, John C.; Cuezva, José M.
H+-ATP synthase
Issue Date19-Dec-2003
PublisherBiochemical Society
CitationBiochem. J. (2004) 378 (17–20)
AbstractRecent findings indicate that the expression of the beta-catalytic subunit of the mitochondrial H+-ATP synthase (beta-F1-ATPase) is depressed in liver, kidney and colon carcinomas, providing further a bioenergetic signature of cancer that is associated with patient survival. In the present study, we performed an analysis of mitochondrial and glycolytic protein markers in breast, gastric and prostate adenocarcinomas, and in squamous oesophageal and lung carcinomas. The expression of mitochondrial and glycolytic markers varied significantly in these carcinomas, when compared with paired normal tissues, with the exception of prostate cancer. Overall, the relative expression of beta-F1-ATPase was significantly reduced in breast and gastric adenocarcinomas, as well as in squamous oesophageal and lung carcinomas, strongly suggesting that alteration of the bioenergetic function of mitochondria is a hallmark of these types of cancer.
Publisher version (URL)http://dx.doi.org/10.1042/BJ20031541
Appears in Collections:(CBM) Artículos
Files in This Item:
File Description SizeFormat 
AIsidoro_BiochemJ_17.pdf144,16 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.